The Americas

  • ‘First’ femtech app to protect user data from governments emerges from stealth

    Menotracker has emerged from stealth, claiming its data privacy tech prevents governments accessing users’ menopause data. The company has teamed up with privacy technology firm ConsentKeys to create what it calls the first women’s health app that will never store users’ personal data. The app is now available in 177 countries and 41 languages, offering [...]

  • Mos Health raises nearly US$1.1m for preventative health platform

    Mos Health has raised about €920k (US$1.1m) in pre-seed funding for an AI preventative health platform aimed at helping users stick to healthier habits. The Polish-American startup is building what it calls an “AI Health Partner”, combining personalised health protocols, or step-by-step plans, with matched supplements to support routine changes. Mos Health says it is [...]

  • Flo Health and Mayo Clinic publish global perimenopause awareness study

    The US ranks sixth for perimenopause knowledge, behind the UK, Ireland, Canada, Australia and the Netherlands, research by the Mayo Clinic and period tracker Flo has revealed. Perimenopause is the transition leading up to a woman’s last menstrual cycle and includes the 12 months afterwards, after which menopause is established as hormone levels change. It [...]

  • P&G acquires digestive medicines company Wonderbelly

    Procter & Gamble has acquired Wonderbelly, adding the digestive wellness brand to its over-the-counter portfolio. Wonderbelly sells products including antacids, gas and bloat relief, and multi-symptom relief treatments. The range is marketed as free of artificial dyes, talc, titanium dioxide, artificial sweeteners and parabens. The vegan, non-GMO products include flavours such as Strawberry [...]

  • FDA-cleared AI detects heart disease from a single view

    AI Point-of-Care Diagnostics company AISAP has announced the publication of a new clinical study in the peer-reviewed journal Frontiers in Digital Health. The research provides clinical evidence that AISAP’s deep learning model can accurately detect significant valvular disease and ventricular dysfunction using only a single, focused ultrasound view, even when the images are acquired by [...]

  • Medtronic invests US$90m in TAVR firm

    Medtronic has finalised a US$90m investment in Anteris Technologies, a Minnesota medtech firm developing TAVR valve technology. Anteris focuses on structural heart technologies and is known for its biomimetic DurAVR transcatheter heart valve (THV) system, which the company says is the first of its kind. The DurAVR valve is made from a single piece of [...]

  • Gifthealth announces Jeremy Richardson as new chief commercial officer

    Gifthealth has announced the appointment of Jeremy Richardson as its new Chief Commercial Officer (CCO). Richardson brings nearly two decades of leadership experience in sales, marketing, trade, and business development across some of the most respected organizations in healthcare. Most recently, he served as Vice President of Strategy & Commercial Growth at Elevance Health. Richardson [...]

  • StuffThatWorks appoints Julie A. Ross as CEO and president

    StuffThatWorks has announced that Julie A. Ross, former CEO of global CRO Advanced Clinical, has joined the company as Chief Executive Officer and president, effective immediately. Ross will lead the company’s next phase of growth as it scales its proprietary patient-derived AI model designed to address the most persistent constraint in pharmaceutical development: lack of [...]

  • PharmaForceIQ acquires Aktana to boost cross-functional engagement in pharma

    PharmaForceIQ has announced its acquisition of Aktana, aligning its cutting-edge digital orchestration platform with the industry’s premier AI-driven field Next-Best-Action (NBA) platform. The strategic move creates the industry’s first optichannel-in-a-box solution for pharma companies – an end-to-end commercial customer engagement system that can go live in as little as 6–8 weeks. This becomes the most [...]

  • Medtronic invests up to US$90m in Anteris

    Medtronic will invest up to US$90m in Anteris Technologies to help fund the next stage of growth and the DurAVR transcatheter heart valve programme. The Australia-founded company said the funding will support execution of its clinical strategy for DurAVR, designed to mimic a healthy human aortic valve and replicate normal aortic blood flow. Transcatheter heart [...]